Chemical Compound
Tamoxifen Citrate; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); I.C.I.46474 citrate; ICI 46474; Istubal; Kessar; Noltam; Nolvadex; Nourytam; Soltamox; TMX; Tamofen; Tamoplex; Tamox-Puren; Tomaxasta; Valodex; Z-Tamoxifen citrate; Zemide
CAS Registry Number
54965-24-1
Primary record
Tamoxifen Citrate; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); I.C.I.46474 citrate; ICI 46474; Istubal; Kessar; Noltam; Nolvadex; Nourytam; Soltamox; TMX; Tamofen; Tamoplex; Tamox-Puren; Tomaxasta; Valodex; Z-Tamoxifen citrate; Zemide
- 库存
- 4,703 克
- 纯度
- 98.5 %
- CAS
- 54965-24-1
化合物标识与属性
- CAS
- 54965-24-1
- PubChem CID
- 2733525
- SMILES
- CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
- Canonical SMILES
- CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
名称与同义词
- Tamoxifen citrate
- Nolvadex
- Istubal
- Zitazonium
- Soltamox
- Kessar
- Zemide
- tamoxifen
- 54965-24-1
- Jenoxifen
- Tomaxasta
- Ledertam
- Nourytam
- Tamofene
- Zynoplex
- Noxitem
- Oncotam
- Tamofen
- Emblon
- Nolgen
- Noltam
- Tamax
- Farmifeno
- Ginarsan
- Nourytan
- Tamoplex
- Tamoxasta
- Caditam
- Tafoxen
- Terimon
- Valodex
- Genox
- Taxus
- Tamoxifencitrate
- Tamoxifen citrate salt
- Tamox-Puren
- Clonoxifen
- Dignotamoxi
- Apo-Tamox
- Estroxyn
- Fentamox
- Kentadex
- Lesporene
- Oestrifen
- Tamoxifeni citras
- Novofen
- Tamaxin
- Tamifen
- Ebefen
- Nolvadex fte
- Novo-Tamoxifen
- Gen-Tamoxifen
- Nolvadex d
- Pms-Tamoxifen
- Tamoxifen (Citrate)
- Nolvadex-D
- citro; tamoxifen
- Z-Tamoxifen citrate
- Oestrifen-10
- Oestrifen-20
- Oestrifen-40
- Citrate, Tamoxifen
- Fentamox 10
- Fentamox 20
- Tamoxifen Citrate?
- Nolvadex (TN)
- Soltamox (TN)
- Prestwick_458
- Kessar 10
- Kessar 20
- Tamoxifen citrate RS
- Tamoxifen (Nolvadex)
- citalopram hydrobromide
- Tamoxifen citrate CRS
- ICI 46474 citrate
- AC1MBZ3O
- RefChem:891063
- Lopac-T-9262
- Tamoxifen Citrate (Nolvadex)
- DTXSID8021301
- CHEMBL786
- C32H37NO8
- I.C.I. 46474 citrate
- UNII-7FRV7310N6
- SCHEMBL6365
- CCRIS 6718
- DTXCID101301
- ICI 46,474
- 7FRV7310N6
- I.C.I.46474 CITRATE
- MFCD00058321
- MLS001055370
- MLS002154210
- ARONIS23853
- NSC-180973
- NSC-757345
- SPECTRUM1500557
- 54965-24-1 (citrate)
- Nolvadex (TN) (AstraZeneca)
- C26H29NO.xC6H8O7
- FQZYTYWMLGAPFJ-OQKDUQJOSA-N
- ICI 46474
- ICI-46474
- NSC180973
- TAMOXIFEN CITRATE [MI]
- CHEBI:9397
- orb1310249
- orb3025056
- Tamoxifen citrate [USAN:JAN]
- TAMOXIFEN CITRATE [JAN]
- C26H29NO.C6H8O7
- Tamoxifen (Citrate) (Standard)
- Tamoxifen citrate (JP18/USP)
- TAMOXIFEN CITRATE [USAN]
- EINECS 259-415-2
- ERK5-2K17
- HMS500M20
- Tamoxifen citrate [USAN:USP:JAN]
- Tamoxifen citrate salt, >=99%
- TAMOXIFEN CITRATE [VANDF]
- s1238
- TAMOXIFEN CITRATE [MART.]
- GLXC-26314
- HMS1568M14
- HMS1921C13
- HMS2092K17
- HMS2095M14
- HMS2232E08
- HMS3263B08
- HMS3675P04
- HMS3712M14
- HMS5079C21
- HMS5080B11
- Pharmakon1600-01500557
- NSC 180973
- TAMOXIFEN CITRATE [USP-RS]
- TAMOXIFEN CITRATE [WHO-DD]
- TAMOXIFEN CITRATE [WHO-IP]
- EX-A5777
- Tox21_110938
- Tox21_202070
- Tox21_300274
- Tox21_501203
- CCG-39629
- EBC-11168
- HY-13757R
- NCGC00024928-06
- NSC757345
- s1972
- SBB080554
- AKOS005111126
- Tox21_110938_1
- CID2733525
- CS-1852
- FT32122
- KS-5046
- LP01203
- TAMOXIFEN CITRATE [ORANGE BOOK]
- CAS-54965-24-1
- TAMOXIFEN CITRATE [EP MONOGRAPH]
- Tamoxifen Citrate USPRS (1643306)
- NCGC00016206-01
- NCGC00016206-02
- NCGC00016206-03
- NCGC00016206-04
- NCGC00016206-05
- NCGC00016206-06
- NCGC00024928-02
- NCGC00024928-23
- NCGC00094450-01
- NCGC00094450-02
- NCGC00094450-03
- NCGC00094450-04
- NCGC00254000-01
- NCGC00259619-01
- NCGC00261888-01
- TAMOXIFEN CITRATE [USP MONOGRAPH]
- TAMOXIFENI CITRAS [WHO-IP LATIN]
- C26-H29-N-O.C6-H8-O7
- C26-H29-N-O.x-C6-H8-O7
- CPD000677949
- HY-13757
- LS-68202
- M936
- SAM002564256
- SC-13399
- SMR000677949
- BCP0726000223
- Tamoxifen Citrate - CAS 54965-24-1
- Tamoxifen citrate for performance test CRS
- AB0006810
- AB2000015
- B1394
- EU-0101203
- FT-0630672
- NS00076420
- SW219368-1
- T2510
- A10885
- A19582
- D00966
- J10303
- K-9859
- T 9262
- 965T241
- SR-01000075523
- (Z)-2-(p-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1)
- 54965-24-1, 10540-29-1 [tamoxifen]
- Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- SR-01000075523-1
- SR-01000075523-3
- SR-01000075523-5
- SR-01000075523-6
- Q27108378
- SR-01000075523-10
- trans-1-(p-beta-Dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-ene citrate
- B0084-304481
- N,N-Dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)ethylamine citrate
- Tamoxifen Citrate For Performance Test EPCRS (T0015000)
- Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- TMX
- (Z)-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate
- Ethylamine, 2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, citrate (Z)-
- Tamoxifen citrate, European Pharmacopoeia (EP) Reference Standard
- (Z)-2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine citrate
- (Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate
- (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate
- 1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene Citrate
- 10540-29-1
- 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
- Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Tamoxifen citrate, United States Pharmacopeia (USP) Reference Standard
- (Z)-2-[ p-(1,2-Diphenyl-1-butenyl)phenoxy]- N, N-dimethylethylamine citrate (1:1)
- (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-ethanamine cirtrate (1:1)
- citric acid;2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine
- Tamoxifen citrate for performance test, European Pharmacopoeia (EP) Reference Standard
- (2-{4-[1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine; 2-hydroxypropane-1,2,3-tricarboxylic acid
- (Z)-(2-(4-(1,2-Diphenylbut-1-enyl)phenoxy)ethyl)dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
- (Z)-[2-[4-(1,2-diphenylbut-1-enyl)phenoxy]ethyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
- (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate
- (Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate
- {2-[4-((1Z)-1,2-diphenylbut-1-enyl)phenoxy]ethyl}dimethylamine, 2-hydroxypropa ne-1,2,3-tricarboxylic acid
- {2-[4-(1,2-Diphenyl-1-buten-1-yl)phenoxy]ethyl}dimethylamine 2-hydroxy-1,2,3-propanetricarboxylate (
- {2-[4-(1,2-diphenyl-1-buten-1-yl)phenoxy]ethyl}dimethylamine 2-hydroxy-1,2,3-propanetricarboxylate (salt)
- {2-[4-(1,2-Diphenyl-1-buten-1-yl)phenoxy]ethyl}dimethylamine 2-hydroxy-1,2,3-propanetricarboxylate salt
- 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid
- 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
- 2-Hydroxypropane-1,2,3-tricarboxylic acid--2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethan-1-amine (1/1)
- 59729-32-7
- 7244-97-5
- Etanamina, 2-[4-[(1Z)]-1,2-difenil-1-buten-1-il fenoxi]-N,N-dimetil-, 2-hidroxi-1,2,3-propanotricarboxilato (1: 1)
- Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate
- Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Ethanamine,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Tamoxifen Citrate; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); I.C.I.46474 citrate; ICI 46474; Istubal; Kessar; Noltam; Nolvadex; Nourytam; Soltamox; TMX; Tamofen; Tamoplex; Tamox-Puren; Tomaxasta; Valodex; Z-Tamoxifen citrate; Zemide